Debates & Insight Ensuring delivery of healthcare professional education Pharma companies always need to know they can get the right information to the right people at the right time.
News Indivior hit hard as generic Suboxone defence crumbles Indivior has suffered a critical defeat in the US courts for opioid addiction product Suboxone Film, opening the door to generic competition and sparking a run on its shares.
News Indivior's once-monthly schizophrenia injection gets US gree... Regulators authorities in the US have approved Indivior’s long-acting injectable treatment for adults with schizophrenia.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
